Hepatic Infarction Caused by Portal Vein Thrombophlebitis Misdiagnosed as Infiltrative Hepatic Malignancy with Neoplastic Thrombus.

Portal vein thrombosis (PVT) is a form of venous thrombosis that usually presents in chronic form without any sequalae in patients with hepatocellular carcinoma (HCC) or liver cirrhosis. Accurate differential diagnosis of bland PVT from neoplastic PVT is an important step for planning treatment options, but the acute form can be challenging. Here we present a case of acute hepatic infarction caused by acute bland PVT combined with pylephlebitis, which was misdiagnosed as infiltrative hepatic malignancy with neoplastic PVT owing to the perplexing imaging results and elevated tumor markers.

[1]  P. Schirmacher,et al.  Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  S. Olliff,et al.  Portal vein thrombosis in cirrhosis: Controversies and latest developments. , 2015, World journal of gastroenterology.

[3]  Y. Chawla,et al.  Portal vein thrombosis. , 2015, Journal of clinical and experimental hepatology.

[4]  H. Schlitt,et al.  Clinical Management of Acute Portal/Mesenteric Vein Thrombosis , 2014, Visceral Medicine.

[5]  Jiani Hu,et al.  Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging , 2014, BMC Cancer.

[6]  S. Mahadeva,et al.  Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding. , 2014, World journal of gastroenterology.

[7]  D. Weisman,et al.  Pylephlebitis: a rare complication of an intra-abdominal infection , 2013, Journal of community hospital internal medicine perspectives.

[8]  A. Singhal,et al.  Elevation of CA 125 and CA 19–9 in patients with end-stage liver disease , 2012, The International journal of biological markers.

[9]  J. Koskinas,et al.  Pylephlebitis: An overview of non-cirrhotic cases and factors related to outcome , 2010, Scandinavian journal of infectious diseases.

[10]  G. Sotiropoulos,et al.  Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  L. Schwartz,et al.  Bland and tumor thrombi in abdominal malignancies: magnetic resonance imaging assessment in a large oncologic patient population , 2010, Abdominal Imaging.

[12]  A. Gasbarrini,et al.  Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. , 2010, World journal of gastroenterology.

[13]  D. Valla,et al.  Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow‐up study , 2010, Hepatology.

[14]  V. Shah Molecular mechanisms of increased intrahepatic resistance in portal hypertension. , 2007, Journal of clinical gastroenterology.

[15]  M. Mori,et al.  Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Clinical Characteristics, Prognosis, and Patient Survival Analysis , 2007, Digestive Diseases and Sciences.

[16]  S. Pavai,et al.  The clinical significance of elevated levels of serum CA 19-9. , 2003, The Medical journal of Malaysia.

[17]  D. Valla Vascular disorders of the liver. , 2003, Acta gastro-enterologica Belgica.

[18]  M. Tublin,et al.  Benign and malignant portal vein thrombosis: differentiation by CT characteristics. , 1997, AJR. American journal of roentgenology.

[19]  W. Steinberg,et al.  Elevated serum levels of tumor marker CA19-9 in acute cholangitis , 1988, Digestive Diseases and Sciences.

[20]  H. Dale,et al.  The control of circulation through the liver , 1932, The Journal of physiology.

[21]  Seong Jin Park,et al.  Portal vein thrombosis: CT features , 2007, Abdominal Imaging.